https://novaprd-lb.newcastle.edu.au/vital/access/manager/Index ${session.getAttribute("locale")} 5 Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:32389 Wed 30 May 2018 14:18:08 AEST ]]> Drug controversy in sport : the socio-ethical and medical issues https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:12677 Wed 24 Jul 2013 22:23:50 AEST ]]> Exploring signal transduction mechanisms in molecularly imprinted polymers for forensic applications https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:15864 Wed 11 Apr 2018 18:14:17 AEST ]]> Surrogates under scrutiny: fallible correlations, fatal consequences https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:17516 Wed 11 Apr 2018 16:36:34 AEST ]]> Ca²⁺ stores regulate ryanodine receptor Ca²⁺ release channels via luminal and cytosolic Ca²⁺ sites https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:3304 Wed 11 Apr 2018 15:22:34 AEST ]]> A school-based resilience intervention to decrease tobacco, alcohol and marijuana use in high school students https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:15445 Wed 11 Apr 2018 14:16:53 AEST ]]> Online alcohol interventions: a systematic review https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:11053 Wed 11 Apr 2018 13:36:58 AEST ]]> Content and functionality of alcohol and other drug websites: results of an online survey https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:11075 Wed 11 Apr 2018 13:10:17 AEST ]]> The triumphant approach: chasing the unwritable book https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:4686 Wed 11 Apr 2018 11:52:19 AEST ]]> Illicit drug use and experience of harm in the night-time economy https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:24287 Wed 11 Apr 2018 10:05:04 AEST ]]> Working with families with parental mental health and/or drug and alcohol issues where there are child protection concerns: inter-agency collaboration https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:32127 Wed 06 Apr 2022 14:02:39 AEST ]]> Probing 3CL protease: Rationally designed chemical moieties for COVID-19 https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:41952 Tue 16 Aug 2022 14:38:19 AEST ]]> Modulation of circulating trimethylamine N-oxide concentrations by dietary supplements and pharmacological agents: a systematic review https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:48343 Tue 14 Mar 2023 17:28:33 AEDT ]]> Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta‐analysis https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:43872 Tue 04 Oct 2022 12:28:52 AEDT ]]> The Australian Longitudinal Study on Women's Health: 1973-1978 (Young) Cohort Survey 4 data, 2006 https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:8545 Thu 30 Jan 2014 14:55:47 AEDT ]]> The Australian Longitudinal Study on Women's Health: 1921-1926 (Old-age) Cohort Survey 3 data, 2002 https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:8558 Thu 30 Jan 2014 14:54:51 AEDT ]]> The Australian Longitudinal Study on Women's Health: 1946-1951 (Mid-age) Cohort Survey 1 data, 1996 https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:8551 Thu 30 Jan 2014 14:46:47 AEDT ]]> The Australian Longitudinal Study on Women's Health: 1973-1978 (Young) Cohort Survey 1 data, 1996 https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:8552 Thu 30 Jan 2014 14:44:51 AEDT ]]> The Australian Longitudinal Study on Women's Health: 1973-1978 (Young) Cohort Survey 2 data, 2000 https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:8556 Thu 30 Jan 2014 14:44:05 AEDT ]]> The Australian Longitudinal Study on Women's Health: 1946-1951 (Mid-age) Cohort Survey 5 data, 2007 https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:8547 Thu 30 Jan 2014 14:43:14 AEDT ]]> The Australian Longitudinal Study on Women's Health: 1921-1926 (Old-age) Cohort Survey 4 data, 2005 https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:8544 Thu 30 Jan 2014 14:42:50 AEDT ]]> The Australian Longitudinal Study on Women's Health: 1921-1926 (Old-age) Cohort Survey 5 data, 2008 https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:8549 Thu 30 Jan 2014 14:42:12 AEDT ]]> The Australian Longitudinal Study on Women's Health: 1946-1951 (Mid-age) Cohort Survey 4 data, 2004 https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:8543 Thu 30 Jan 2014 14:41:07 AEDT ]]> The Australian Longitudinal Study on Women's Health: 1946-1951 (Mid-age) Cohort Survey 2 data, 1998 https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:8554 Thu 30 Jan 2014 14:40:39 AEDT ]]> The Australian Longitudinal Study on Women's Health: 1973-1978 (Young) Cohort Survey 4 data - Child data, 2006 https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:8546 Thu 30 Jan 2014 14:40:12 AEDT ]]> The Australian Longitudinal Study on Women's Health: 1921-1926 (Old-age) Cohort Survey 1 data, 1996 https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:8550 Thu 30 Jan 2014 14:39:42 AEDT ]]> The Australian Longitudinal Study on Women's Health: 1946-1951 (Mid-age) Cohort Survey 3 data, 2001 https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:8559 Thu 30 Jan 2014 14:38:53 AEDT ]]> The Australian Longitudinal Study on Women's Health: 1973-1978 (Young) Cohort Survey 3 data, 2003 https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:8542 Thu 30 Jan 2014 14:38:23 AEDT ]]> The Australian Longitudinal Study on Women's Health: 1946-1951 (Mid-age) Cohort Survey 5 data - Medications, 2007 https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:8548 Thu 30 Jan 2014 14:38:03 AEDT ]]> The Australian Longitudinal Study on Women's Health: 1921-1926 (Old-age) Cohort Survey 2 data, 1999 https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:8555 Thu 30 Jan 2014 14:36:56 AEDT ]]> The sulfonadyns: a class of aryl sulfonamides inhibiting dynamin I GTPase and clathrin mediated endocytosis are anti-seizure in animal models https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:54007 Thu 25 Jan 2024 13:53:31 AEDT ]]> Polysubstance use in treatment seekers who inject amphetamine: drug use profiles, injecting practices and quality of life https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:32783 Low-polydrug (n = 491), (2) Opiates-polydrug (n = 123), and (3) Alcohol-polydrug (n = 213). There was a trend for the Low-polydrug class to demonstrate better functioning and safer injecting practices than the Opiates-polydrug and Alcohol-polydrug classes. Conclusion: The results suggest that the majority of people accessing treatment who inject amphetamine as their primary drug of choice have a low probability of heroin or other opiate use. It is important that future research consider whether traditional harm minimisation strategies are appropriate for people who primarily inject amphetamine.]]> Thu 17 Feb 2022 09:25:00 AEDT ]]> Drug treatment for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:48407 Thu 16 Mar 2023 14:03:45 AEDT ]]> Pharmacological enrichment of polygenic risk for precision medicine in complex disorders https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:41990 Thu 10 Aug 2023 12:12:50 AEST ]]> Does the Presence of On-Site Medical Services at Outdoor Music Festivals Affect Attendees' Planned Alcohol and Recreational Drug Use? https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:40268 10%) agreement (range 11%-46%; or 2,200-9,200 attendees for a 20,000-person festival) at both festivals that the absence of medical services would affect attendees’ planned use of alcohol and recreational drugs. Conclusions: This study found that attendees surveyed at two geographically and musically distinct OMFs had high but differing rates of planned alcohol and recreational drug use, and that the presence of on-site medical services may impact attendees’ perceptions of substance use risk. Future research will aim to address the limitations of this study to clarify these findings and their implications.]]> Thu 07 Jul 2022 12:09:52 AEST ]]> The effect of decontamination procedures on the pharmacokinetics of venlafaxine in overdose https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:7558 Sat 24 Mar 2018 08:42:05 AEDT ]]> Inter-rater reliability of manual QT measurement and prediction of abnormal QT,HR pairs https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:7333 Sat 24 Mar 2018 08:35:14 AEDT ]]> Placebo https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:6650 Sat 24 Mar 2018 07:46:18 AEDT ]]> Challenges and progress in adverse event ascertainment and reporting in clinical trials https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:340 Sat 24 Mar 2018 07:42:26 AEDT ]]> Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: The ETHOS study https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:28384 Sat 24 Mar 2018 07:36:04 AEDT ]]> Vietnamese medicinal plants as potential anti-cancer agent https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:28960 Sat 24 Mar 2018 07:29:32 AEDT ]]> Motor accidents and blood samples in New South Wales https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:4701 Sat 24 Mar 2018 07:21:48 AEDT ]]> A prospective cohort study of trends in self-poisoning, Newcastle, Australia, 1987-2012: plus ça change, plus c'est la même chose https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:24683 Sat 24 Mar 2018 07:10:55 AEDT ]]> Is disinvestment from alcohol and drug treatment services associated with treatment access, completions and related harm? An analysis of English expenditure and outcomes data https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:44733 Mon 24 Oct 2022 08:28:25 AEDT ]]> Fatherhood Research Bulletin https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:32318 Mon 23 Sep 2019 12:48:22 AEST ]]> Fatherhood Research Bulletin https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:32320 Mon 23 Sep 2019 12:07:14 AEST ]]> Potential simple and multifactorial drug-gene interactions of tricyclic antidepressants in older Australians https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:32298 Mon 23 Sep 2019 11:17:56 AEST ]]> Impact of Patients Presenting with Alcohol and/or Drug Intoxication on In-Event Health Care Services at Mass-Gathering Events: An Integrative Literature Review https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:47601 Mon 23 Jan 2023 16:34:36 AEDT ]]> Are Medicinal Plants an Alternative Strategy to Combat COVID-19? https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:54715 Mon 18 Mar 2024 15:49:06 AEDT ]]> The Association between Problematic Use of Alcohol and Drugs and Repeat Self-Harm and Suicidal Ideation: Insights from a Population-Based Administrative Health Data Set https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:51916 Fri 22 Sep 2023 10:40:39 AEST ]]> Symbolic regression modeling of drug responses https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:35150 Fri 21 Jun 2019 14:31:03 AEST ]]> Glucagon-like peptide 1 agonists for treatment of patients with type 2 diabetes who fail metformin monotherapy: systematic review and meta-analysis of economic evaluation studies https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:40026 2=0%), US$3857.34 (95% CI US$−7293.93 to US$15 008.61, I2=45.9%), US$37 577.74 (95% CI US$−649.02 to US$75 804.50, I2=92.4%) and US$14 062.42 (95% CI US$8168.69 to US$19 956.15, I2=86.4%), respectively. GLP1s were statistically significantly cost-effective compared with insulins, but not compared with DPP4i, sulfonylureas, and TZDs. Among GLP1s, liraglutide was more cost-effective compared with lixisenatide, but not compared with exenatide, with corresponding pooled INBs of US$4555.09 (95% CI US$3992.60 to US$5117.59, I2=0) and US$728.46 (95% CI US$−1436.14 to US$2893.07, I2=0), respectively. Conclusion: GLP1 agonists are a cost-effective choice compared with insulins, but not compared with DPP4i, sulfonylureas and TZDs. PROSPERO registration number: CRD42018105193.]]> Fri 15 Jul 2022 10:11:12 AEST ]]>